Loma Linda University Health Education Consortium Hematology and Medical Oncology

Topics

• Hematopoietic Stem Cell Transplantation 87
• CAR-T cell therapy research 76
• Acute Myeloid Leukemia Research 62
• Acute Lymphoblastic Leukemia research 53
• Lymphoma Diagnosis and Treatment 46
• Parkinson's Disease Mechanisms and Treatments 30
• Cancer Immunotherapy and Biomarkers 28
• Neurological disorders and treatments 26
• Chronic Lymphocytic Leukemia Research 21
• Chronic Myeloid Leukemia Treatments 21
• Multiple Myeloma Research and Treatments 19
• COVID-19 and healthcare impacts 17

Most cited

1. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 538 citations · Shagufta Shaheen

2. Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.

   The New England journal of medicine · 2025 · 127 citations · Shagufta Shaheen

3. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.

   Nature medicine · 2021 · 534 citations · Parveen Shiraz

4. Development of Immunotherapy Combination Strategies in Cancer.

   Cancer discovery · 2021 · 281 citations · Justin Moyers

5. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2021 · 260 citations · Gayathri Nagaraj

6. Donor regulatory T-cell therapy to prevent graft-versus-host disease.

   Blood · 2025 · 40 citations · Parveen Shiraz